Vascular complications uncommon in study of latest-generation arterial closure device
No major vascular complications were seen in the ELITE trial using the latest-generation PerQseal Elite (Vivasure Medical), a patch-based, resorbable, sutureless vascular device for...
Terumo Aortic announces launch of Fenestrated Treo pivotal IDE study in USA
Terumo Aortic today announced enrolment of the first patient in the Fenestrated Treo pivotal investigational device exemption (IDE) study in the USA. This study...
“We need to look at the totality of evidence”: VIVA panellists examine SWEDEPAD findings
A focused session at the 2025 Vascular Interventional Advances (VIVA) conference (2–5 November, Las Vegas, USA) homed in on the latest findings from the...
Vesalio receives two US FDA 510(k) clearances for aspiration devices
Vesalio recently announced two new US Food and Drug Administration (FDA) 510(k) clearances for its aspiration devices, designed for peripheral and neurovascular applications.
By integrating...
